Chemoinformaics analysis of D-alanine, N-propargyloxycarbonyl-, isohexyl ester
| Molecular Weight | 255.314 | nRot | 7 |
| Heavy Atom Molecular Weight | 234.146 | nRig | 3 |
| Exact Molecular Weight | 255.147 | nRing | 0 |
| Solubility: LogS | -2.603 | nHRing | 0 |
| Solubility: LogP | 2.446 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 40.0207 |
| nHD | 1 | BPOL | 26.8453 |
| QED | 0.427 |
| Synth | 2.919 |
| Natural Product Likeliness | -0.497 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.399 |
| MDCK | 0.000100679 |
| BBB | 0.991 |
| PPB | 0.855434 |
| VDSS | 0.986 |
| FU | 0.097982 |
| CYP1A2-inh | 0.955 |
| CYP1A2-sub | 0.397 |
| CYP2c19-inh | 0.692 |
| CYP2c19-sub | 0.652 |
| CYP2c9-inh | 0.344 |
| CYP2c9-sub | 0.249 |
| CYP2d6-inh | 0.09 |
| CYP2d6-sub | 0.184 |
| CYP3a4-inh | 0.407 |
| CYP3a4-sub | 0.272 |
| CL | 6.423 |
| T12 | 0.677 |
| hERG | 0.051 |
| Ames | 0.04 |
| ROA | 0.054 |
| SkinSen | 0.342 |
| Carcinogencity | 0.121 |
| EI | 0.189 |
| Respiratory | 0.463 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.734358 |